Gene Symbol | Gene ID | Gene Info |
---|---|---|
PAX5
|
ENSG00000196092.8 | paired box 5 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_37034526_37034714 | PAX5 | 517 | 0.807567 | 0.71 | 3.2e-02 | Click! |
chr9_37034211_37034515 | PAX5 | 260 | 0.928204 | 0.66 | 5.1e-02 | Click! |
chr9_37033840_37034100 | PAX5 | 58 | 0.977965 | 0.57 | 1.1e-01 | Click! |
chr9_37029511_37029662 | PAX5 | 4442 | 0.235898 | -0.56 | 1.1e-01 | Click! |
chr9_37027027_37027178 | PAX5 | 6926 | 0.213223 | 0.54 | 1.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_56408975_56409725 | 3.95 |
MIR142 |
microRNA 142 |
519 |
0.63 |
chr19_2083107_2083981 | 3.56 |
MOB3A |
MOB kinase activator 3A |
1847 |
0.21 |
chrX_128914480_128914899 | 3.42 |
SASH3 |
SAM and SH3 domain containing 3 |
729 |
0.68 |
chr17_56410108_56410593 | 3.13 |
MIR142 |
microRNA 142 |
481 |
0.66 |
chr1_161038546_161039545 | 2.87 |
ARHGAP30 |
Rho GTPase activating protein 30 |
411 |
0.65 |
chr5_169724277_169724686 | 2.70 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
750 |
0.71 |
chr11_67171589_67172183 | 2.62 |
TBC1D10C |
TBC1 domain family, member 10C |
226 |
0.8 |
chr15_89183058_89183298 | 2.43 |
ISG20 |
interferon stimulated exonuclease gene 20kDa |
994 |
0.5 |
chr19_49838375_49839003 | 2.31 |
CD37 |
CD37 molecule |
5 |
0.95 |
chr19_15574418_15574723 | 2.30 |
RASAL3 |
RAS protein activator like 3 |
812 |
0.5 |
chr17_8868395_8868683 | 2.27 |
PIK3R5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
485 |
0.85 |
chr19_6481304_6482171 | 2.15 |
DENND1C |
DENN/MADD domain containing 1C |
27 |
0.95 |
chr2_233926827_233927087 | 2.08 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
1768 |
0.35 |
chr17_33864237_33864745 | 2.02 |
SLFN12L |
schlafen family member 12-like |
389 |
0.76 |
chr22_37639373_37639682 | 1.96 |
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
761 |
0.58 |
chr16_30196259_30196584 | 1.88 |
RP11-455F5.5 |
|
143 |
0.71 |
chr10_114135452_114136486 | 1.87 |
ACSL5 |
acyl-CoA synthetase long-chain family member 5 |
12 |
0.98 |
chr17_4542943_4543325 | 1.86 |
ALOX15 |
arachidonate 15-lipoxygenase |
43 |
0.96 |
chr15_40599321_40599893 | 1.85 |
PLCB2 |
phospholipase C, beta 2 |
419 |
0.68 |
chr5_169722669_169722820 | 1.85 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
2487 |
0.33 |
chr16_28995938_28996254 | 1.81 |
LAT |
linker for activation of T cells |
51 |
0.94 |
chr21_46339485_46339636 | 1.78 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
1210 |
0.27 |
chr2_106776490_106776797 | 1.77 |
UXS1 |
UDP-glucuronate decarboxylase 1 |
397 |
0.89 |
chr16_3627016_3627406 | 1.76 |
NLRC3 |
NLR family, CARD domain containing 3 |
181 |
0.93 |
chr5_176936066_176936393 | 1.76 |
DOK3 |
docking protein 3 |
598 |
0.57 |
chr6_11381781_11382025 | 1.75 |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
629 |
0.82 |
chr17_43301591_43301923 | 1.74 |
CTD-2020K17.1 |
|
2168 |
0.16 |
chr22_18260542_18260943 | 1.74 |
BID |
BH3 interacting domain death agonist |
3311 |
0.23 |
chr10_11221601_11222262 | 1.72 |
RP3-323N1.2 |
|
8592 |
0.22 |
chr11_128595669_128596120 | 1.72 |
SENCR |
smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA |
29976 |
0.16 |
chr3_196365832_196366436 | 1.72 |
NRROS |
negative regulator of reactive oxygen species |
423 |
0.51 |
chr1_6086479_6086932 | 1.70 |
KCNAB2 |
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
325 |
0.88 |
chr19_39825870_39826313 | 1.69 |
GMFG |
glia maturation factor, gamma |
554 |
0.58 |
chr2_69002223_69002932 | 1.69 |
ARHGAP25 |
Rho GTPase activating protein 25 |
505 |
0.84 |
chr12_7062878_7063032 | 1.67 |
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
2417 |
0.09 |
chr14_67954778_67955432 | 1.63 |
TMEM229B |
transmembrane protein 229B |
344 |
0.87 |
chr16_89831548_89831767 | 1.62 |
FANCA |
Fanconi anemia, complementation group A |
20187 |
0.11 |
chr8_134085908_134086059 | 1.62 |
SLA |
Src-like-adaptor |
13380 |
0.24 |
chr5_176856785_176856956 | 1.61 |
GRK6 |
G protein-coupled receptor kinase 6 |
3015 |
0.13 |
chr7_38398847_38399253 | 1.61 |
AMPH |
amphiphysin |
103663 |
0.08 |
chr19_10959149_10959379 | 1.59 |
C19orf38 |
chromosome 19 open reading frame 38 |
186 |
0.91 |
chrX_153190817_153191535 | 1.58 |
ARHGAP4 |
Rho GTPase activating protein 4 |
522 |
0.6 |
chr12_117536177_117536841 | 1.56 |
TESC |
tescalcin |
742 |
0.76 |
chr6_35266459_35266895 | 1.55 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
1048 |
0.51 |
chr22_37257050_37257437 | 1.52 |
NCF4 |
neutrophil cytosolic factor 4, 40kDa |
213 |
0.91 |
chr11_415798_416116 | 1.51 |
SIGIRR |
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
961 |
0.35 |
chr11_63656035_63656583 | 1.48 |
MARK2 |
MAP/microtubule affinity-regulating kinase 2 |
141 |
0.94 |
chr7_150264558_150265605 | 1.46 |
GIMAP4 |
GTPase, IMAP family member 4 |
557 |
0.78 |
chr1_26872928_26873171 | 1.44 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
706 |
0.6 |
chr1_160680712_160681035 | 1.43 |
CD48 |
CD48 molecule |
720 |
0.63 |
chr20_4802726_4803481 | 1.43 |
RASSF2 |
Ras association (RalGDS/AF-6) domain family member 2 |
1188 |
0.5 |
chr11_47399612_47399968 | 1.41 |
SPI1 |
spleen focus forming virus (SFFV) proviral integration oncogene |
152 |
0.91 |
chr11_2323518_2323777 | 1.41 |
TSPAN32 |
tetraspanin 32 |
267 |
0.57 |
chr19_6773186_6773436 | 1.40 |
VAV1 |
vav 1 guanine nucleotide exchange factor |
342 |
0.82 |
chr1_160616059_160616370 | 1.40 |
SLAMF1 |
signaling lymphocytic activation molecule family member 1 |
597 |
0.7 |
chr17_6560192_6560644 | 1.40 |
ENSG00000264468 |
. |
1590 |
0.21 |
chr13_30950425_30950835 | 1.39 |
KATNAL1 |
katanin p60 subunit A-like 1 |
69009 |
0.11 |
chr12_57870637_57870788 | 1.38 |
ARHGAP9 |
Rho GTPase activating protein 9 |
855 |
0.36 |
chr22_37679105_37679462 | 1.38 |
CYTH4 |
cytohesin 4 |
755 |
0.62 |
chr9_130538812_130538999 | 1.36 |
SH2D3C |
SH2 domain containing 3C |
2115 |
0.15 |
chr1_53099841_53100010 | 1.35 |
FAM159A |
family with sequence similarity 159, member A |
909 |
0.57 |
chr17_76129729_76129891 | 1.35 |
TMC6 |
transmembrane channel-like 6 |
1322 |
0.29 |
chr2_120934672_120935030 | 1.35 |
ENSG00000202046 |
. |
14970 |
0.19 |
chr2_113933295_113933446 | 1.34 |
AC016683.5 |
|
433 |
0.74 |
chr12_47609308_47609580 | 1.34 |
PCED1B |
PC-esterase domain containing 1B |
608 |
0.77 |
chr17_43304385_43304811 | 1.32 |
CTD-2020K17.1 |
|
5009 |
0.11 |
chr7_5571391_5571891 | 1.32 |
ACTB |
actin, beta |
1301 |
0.32 |
chr17_25958202_25958709 | 1.31 |
LGALS9 |
lectin, galactoside-binding, soluble, 9 |
222 |
0.92 |
chr6_170403243_170403627 | 1.31 |
RP11-302L19.1 |
|
74306 |
0.11 |
chr14_91866607_91866949 | 1.30 |
CCDC88C |
coiled-coil domain containing 88C |
16912 |
0.22 |
chr19_52149205_52149440 | 1.30 |
SIGLEC5 |
sialic acid binding Ig-like lectin 5 |
524 |
0.49 |
chr6_10528716_10529334 | 1.29 |
GCNT2 |
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) |
436 |
0.83 |
chr1_151129106_151129618 | 1.28 |
SCNM1 |
sodium channel modifier 1 |
222 |
0.51 |
chr19_3179462_3180177 | 1.28 |
S1PR4 |
sphingosine-1-phosphate receptor 4 |
1083 |
0.38 |
chr8_27183037_27183778 | 1.28 |
PTK2B |
protein tyrosine kinase 2 beta |
326 |
0.9 |
chr11_63974230_63974581 | 1.27 |
FERMT3 |
fermitin family member 3 |
199 |
0.84 |
chr15_70827822_70828052 | 1.27 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
166683 |
0.04 |
chr10_11212951_11213685 | 1.27 |
RP3-323N1.2 |
|
21 |
0.98 |
chr11_63304045_63305245 | 1.27 |
RARRES3 |
retinoic acid receptor responder (tazarotene induced) 3 |
352 |
0.84 |
chr1_9714142_9714379 | 1.26 |
C1orf200 |
chromosome 1 open reading frame 200 |
384 |
0.82 |
chr1_209930701_209930998 | 1.26 |
TRAF3IP3 |
TRAF3 interacting protein 3 |
994 |
0.46 |
chr17_62009073_62009653 | 1.26 |
CD79B |
CD79b molecule, immunoglobulin-associated beta |
258 |
0.86 |
chr16_30195940_30196215 | 1.26 |
CORO1A |
coronin, actin binding protein, 1A |
8 |
0.7 |
chr7_5572395_5572659 | 1.26 |
ACTB |
actin, beta |
2187 |
0.2 |
chr2_158298330_158298802 | 1.25 |
ENSG00000216054 |
. |
504 |
0.79 |
chr2_158299843_158300108 | 1.25 |
CYTIP |
cytohesin 1 interacting protein |
679 |
0.68 |
chr5_171606319_171606957 | 1.24 |
STK10 |
serine/threonine kinase 10 |
8752 |
0.2 |
chr19_55765720_55766271 | 1.24 |
PPP6R1 |
protein phosphatase 6, regulatory subunit 1 |
1142 |
0.27 |
chr2_43449003_43449546 | 1.24 |
ZFP36L2 |
ZFP36 ring finger protein-like 2 |
4474 |
0.26 |
chr3_13056382_13056660 | 1.23 |
IQSEC1 |
IQ motif and Sec7 domain 1 |
27985 |
0.23 |
chr22_24038975_24039251 | 1.23 |
RGL4 |
ral guanine nucleotide dissociation stimulator-like 4 |
442 |
0.74 |
chr16_29675034_29675898 | 1.22 |
QPRT |
quinolinate phosphoribosyltransferase |
866 |
0.35 |
chr2_11884173_11884474 | 1.22 |
AC012456.4 |
|
1104 |
0.39 |
chr6_144655565_144656031 | 1.22 |
RP1-91J24.3 |
|
1361 |
0.51 |
chr12_25205549_25206037 | 1.21 |
LRMP |
lymphoid-restricted membrane protein |
119 |
0.97 |
chr10_73532392_73533248 | 1.21 |
C10orf54 |
chromosome 10 open reading frame 54 |
435 |
0.83 |
chr17_27466417_27467105 | 1.21 |
MYO18A |
myosin XVIIIA |
675 |
0.43 |
chr1_9687685_9687898 | 1.20 |
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
23999 |
0.14 |
chr17_76120955_76121350 | 1.20 |
TMC6 |
transmembrane channel-like 6 |
1949 |
0.21 |
chr17_61775506_61775979 | 1.20 |
LIMD2 |
LIM domain containing 2 |
780 |
0.58 |
chr1_206749084_206749354 | 1.20 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
18726 |
0.14 |
chr11_5246233_5246455 | 1.20 |
ENSG00000221031 |
. |
475 |
0.58 |
chr14_93119065_93119528 | 1.20 |
RIN3 |
Ras and Rab interactor 3 |
450 |
0.88 |
chr1_27669467_27669709 | 1.20 |
SYTL1 |
synaptotagmin-like 1 |
131 |
0.93 |
chr10_6585169_6585583 | 1.20 |
PRKCQ |
protein kinase C, theta |
36825 |
0.22 |
chr17_72733506_72734386 | 1.20 |
RAB37 |
RAB37, member RAS oncogene family |
575 |
0.59 |
chr20_4794500_4794911 | 1.19 |
RASSF2 |
Ras association (RalGDS/AF-6) domain family member 2 |
1064 |
0.55 |
chr11_64631996_64632371 | 1.19 |
EHD1 |
EH-domain containing 1 |
10955 |
0.1 |
chr16_84628364_84628721 | 1.19 |
RP11-61F12.1 |
|
543 |
0.75 |
chr17_78237440_78238417 | 1.19 |
RNF213 |
ring finger protein 213 |
3259 |
0.2 |
chr5_150593652_150593827 | 1.19 |
GM2A |
GM2 ganglioside activator |
2028 |
0.31 |
chr15_81592474_81592729 | 1.18 |
IL16 |
interleukin 16 |
844 |
0.63 |
chr12_7061050_7061251 | 1.18 |
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
612 |
0.41 |
chr11_33915442_33916212 | 1.18 |
LMO2 |
LIM domain only 2 (rhombotin-like 1) |
1991 |
0.35 |
chr1_209930126_209930277 | 1.17 |
TRAF3IP3 |
TRAF3 interacting protein 3 |
677 |
0.62 |
chr12_122097092_122097456 | 1.17 |
MORN3 |
MORN repeat containing 3 |
10286 |
0.18 |
chr6_20206769_20207068 | 1.17 |
RP11-239H6.2 |
|
5400 |
0.25 |
chr11_72527375_72527681 | 1.17 |
ATG16L2 |
autophagy related 16-like 2 (S. cerevisiae) |
2051 |
0.23 |
chr15_40599985_40600136 | 1.17 |
PLCB2 |
phospholipase C, beta 2 |
22 |
0.95 |
chr14_52327497_52328482 | 1.17 |
GNG2 |
guanine nucleotide binding protein (G protein), gamma 2 |
53 |
0.98 |
chr19_35504895_35505204 | 1.17 |
CTD-2527I21.14 |
|
11190 |
0.1 |
chr20_36932966_36933127 | 1.17 |
BPI |
bactericidal/permeability-increasing protein |
521 |
0.74 |
chr1_31229648_31230364 | 1.16 |
LAPTM5 |
lysosomal protein transmembrane 5 |
661 |
0.67 |
chr9_95821872_95822074 | 1.16 |
SUSD3 |
sushi domain containing 3 |
912 |
0.56 |
chr15_81592157_81592376 | 1.16 |
IL16 |
interleukin 16 |
509 |
0.8 |
chr15_75077997_75078148 | 1.15 |
CSK |
c-src tyrosine kinase |
2813 |
0.16 |
chr22_30663049_30663222 | 1.15 |
OSM |
oncostatin M |
306 |
0.81 |
chr2_158296405_158296556 | 1.14 |
CYTIP |
cytohesin 1 interacting protein |
554 |
0.73 |
chr6_24933928_24934155 | 1.14 |
FAM65B |
family with sequence similarity 65, member B |
2147 |
0.37 |
chr19_18507804_18508682 | 1.14 |
LRRC25 |
leucine rich repeat containing 25 |
178 |
0.89 |
chr13_30510013_30510639 | 1.14 |
LINC00572 |
long intergenic non-protein coding RNA 572 |
9538 |
0.3 |
chr1_45189401_45189653 | 1.13 |
ENSG00000199377 |
. |
1953 |
0.17 |
chr19_8641491_8641716 | 1.13 |
MYO1F |
myosin IF |
719 |
0.54 |
chr16_88860166_88860463 | 1.12 |
PIEZO1 |
piezo-type mechanosensitive ion channel component 1 |
8695 |
0.09 |
chr9_134152676_134153362 | 1.12 |
FAM78A |
family with sequence similarity 78, member A |
1085 |
0.5 |
chr21_47971792_47972029 | 1.12 |
ENSG00000272283 |
. |
16201 |
0.17 |
chr19_3136242_3137376 | 1.12 |
GNA15 |
guanine nucleotide binding protein (G protein), alpha 15 (Gq class) |
618 |
0.58 |
chr20_1666477_1666686 | 1.12 |
ENSG00000242348 |
. |
19575 |
0.16 |
chr9_92094215_92094379 | 1.12 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
508 |
0.83 |
chr14_106854492_106854843 | 1.12 |
IGHV3-37 |
immunoglobulin heavy variable 3-37 (pseudogene) |
1641 |
0.1 |
chr1_36042987_36043882 | 1.11 |
RP4-728D4.2 |
|
104 |
0.95 |
chr11_65185943_65186437 | 1.11 |
ENSG00000245532 |
. |
25739 |
0.09 |
chr1_183557911_183558259 | 1.11 |
NCF2 |
neutrophil cytosolic factor 2 |
1631 |
0.39 |
chr11_63974616_63975431 | 1.11 |
FERMT3 |
fermitin family member 3 |
266 |
0.78 |
chr22_17718076_17718349 | 1.10 |
CECR1 |
cat eye syndrome chromosome region, candidate 1 |
15333 |
0.2 |
chr1_207095826_207096146 | 1.10 |
FAIM3 |
Fas apoptotic inhibitory molecule 3 |
555 |
0.71 |
chr5_171612568_171612893 | 1.10 |
STK10 |
serine/threonine kinase 10 |
2660 |
0.27 |
chr7_77325834_77326254 | 1.10 |
RSBN1L |
round spermatid basic protein 1-like |
284 |
0.94 |
chr7_38389675_38390189 | 1.10 |
AMPH |
amphiphysin |
112781 |
0.07 |
chr17_73839317_73839828 | 1.09 |
UNC13D |
unc-13 homolog D (C. elegans) |
278 |
0.8 |
chr9_100745668_100746275 | 1.09 |
ANP32B |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
328 |
0.85 |
chr1_29255082_29255406 | 1.09 |
EPB41 |
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
14153 |
0.18 |
chr5_169720489_169720914 | 1.09 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
4530 |
0.26 |
chr10_135089818_135090113 | 1.09 |
ADAM8 |
ADAM metallopeptidase domain 8 |
389 |
0.74 |
chr15_75069286_75069492 | 1.08 |
CSK |
c-src tyrosine kinase |
5009 |
0.13 |
chr15_75079322_75079822 | 1.08 |
CSK |
c-src tyrosine kinase |
1313 |
0.27 |
chr19_2084034_2084229 | 1.08 |
MOB3A |
MOB kinase activator 3A |
1260 |
0.31 |
chr1_154378708_154379562 | 1.08 |
RP11-350G8.5 |
|
95 |
0.93 |
chr17_78754518_78754794 | 1.08 |
RP11-28G8.1 |
|
24776 |
0.21 |
chr16_89043094_89043288 | 1.08 |
CBFA2T3 |
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
210 |
0.92 |
chr10_14611757_14612021 | 1.08 |
FAM107B |
family with sequence similarity 107, member B |
2140 |
0.39 |
chr19_16477276_16478284 | 1.07 |
EPS15L1 |
epidermal growth factor receptor pathway substrate 15-like 1 |
5016 |
0.17 |
chr8_22437861_22438169 | 1.07 |
PDLIM2 |
PDZ and LIM domain 2 (mystique) |
12 |
0.95 |
chr22_37679801_37680063 | 1.07 |
CYTH4 |
cytohesin 4 |
1404 |
0.39 |
chr16_29816076_29816359 | 1.07 |
MAZ |
MYC-associated zinc finger protein (purine-binding transcription factor) |
1210 |
0.2 |
chr19_16254556_16255035 | 1.06 |
HSH2D |
hematopoietic SH2 domain containing |
249 |
0.88 |
chr19_48835948_48836196 | 1.06 |
EMP3 |
epithelial membrane protein 3 |
7207 |
0.11 |
chr5_39201497_39202174 | 1.06 |
FYB |
FYN binding protein |
1294 |
0.59 |
chr19_52132706_52132857 | 1.06 |
SIGLEC5 |
sialic acid binding Ig-like lectin 5 |
807 |
0.48 |
chr1_225654970_225655492 | 1.06 |
RP11-496N12.6 |
|
2186 |
0.34 |
chr11_67205288_67205516 | 1.06 |
PTPRCAP |
protein tyrosine phosphatase, receptor type, C-associated protein |
136 |
0.87 |
chr2_99346083_99347252 | 1.05 |
MGAT4A |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A |
44 |
0.98 |
chr14_94422010_94422176 | 1.05 |
ASB2 |
ankyrin repeat and SOCS box containing 2 |
168 |
0.94 |
chr15_40600356_40600529 | 1.05 |
PLCB2 |
phospholipase C, beta 2 |
319 |
0.77 |
chr11_14665333_14666638 | 1.05 |
PDE3B |
phosphodiesterase 3B, cGMP-inhibited |
608 |
0.56 |
chr17_76123581_76124282 | 1.05 |
TMC6 |
transmembrane channel-like 6 |
780 |
0.49 |
chr5_95153586_95154314 | 1.04 |
GLRX |
glutaredoxin (thioltransferase) |
4465 |
0.17 |
chr17_43487096_43487739 | 1.04 |
ARHGAP27 |
Rho GTPase activating protein 27 |
335 |
0.82 |
chr14_93118654_93119048 | 1.04 |
RIN3 |
Ras and Rab interactor 3 |
5 |
0.99 |
chr11_1779321_1779700 | 1.04 |
RP11-295K3.1 |
|
771 |
0.4 |
chr17_75450125_75450790 | 1.04 |
SEPT9 |
septin 9 |
295 |
0.88 |
chr21_46902934_46903368 | 1.04 |
COL18A1 |
collagen, type XVIII, alpha 1 |
7038 |
0.21 |
chr22_50630477_50630948 | 1.04 |
RP3-402G11.25 |
|
119 |
0.86 |
chr2_54786735_54787181 | 1.03 |
SPTBN1 |
spectrin, beta, non-erythrocytic 1 |
1427 |
0.42 |
chr11_64510621_64511071 | 1.03 |
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
415 |
0.76 |
chr17_2699201_2699651 | 1.03 |
RAP1GAP2 |
RAP1 GTPase activating protein 2 |
306 |
0.89 |
chr5_138850718_138851297 | 1.03 |
AC138517.1 |
Uncharacterized protein |
1101 |
0.4 |
chr1_6053732_6054005 | 1.03 |
KCNAB2 |
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
1097 |
0.4 |
chr2_175498427_175499207 | 1.02 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
490 |
0.83 |
chr16_87990211_87990954 | 1.02 |
BANP |
BTG3 associated nuclear protein |
2895 |
0.27 |
chr1_53099023_53099709 | 1.02 |
FAM159A |
family with sequence similarity 159, member A |
350 |
0.87 |
chr19_52133397_52133630 | 1.02 |
SIGLEC5 |
sialic acid binding Ig-like lectin 5 |
75 |
0.95 |
chr11_2291181_2291518 | 1.02 |
ASCL2 |
achaete-scute family bHLH transcription factor 2 |
833 |
0.53 |
chr11_58343050_58343342 | 1.01 |
LPXN |
leupaxin |
138 |
0.95 |
chr2_233927814_233927965 | 1.01 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
2700 |
0.26 |
chr10_3710614_3710914 | 1.00 |
RP11-184A2.3 |
|
82495 |
0.1 |
chr4_2801328_2801581 | 1.00 |
SH3BP2 |
SH3-domain binding protein 2 |
729 |
0.69 |
chr3_187086208_187087126 | 1.00 |
RTP4 |
receptor (chemosensory) transporter protein 4 |
547 |
0.82 |
chr7_26333293_26333815 | 1.00 |
SNX10 |
sorting nexin 10 |
880 |
0.67 |
chrX_56590218_56591666 | 1.00 |
UBQLN2 |
ubiquilin 2 |
916 |
0.74 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 4.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.2 | 7.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) positive regulation of gamma-delta T cell differentiation(GO:0045588) |
1.2 | 3.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
1.0 | 2.9 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.8 | 3.3 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.8 | 2.4 | GO:0033622 | integrin activation(GO:0033622) |
0.8 | 0.8 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.7 | 2.2 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.7 | 1.4 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.7 | 2.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.7 | 3.6 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.7 | 2.1 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.7 | 2.0 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.7 | 0.7 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.6 | 2.6 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.6 | 1.8 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.6 | 4.2 | GO:0007172 | signal complex assembly(GO:0007172) |
0.6 | 2.4 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.6 | 1.8 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.6 | 2.9 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) mature B cell differentiation(GO:0002335) |
0.6 | 1.7 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.6 | 2.3 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.6 | 1.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.6 | 1.7 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.6 | 0.6 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.6 | 1.7 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.6 | 0.6 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.5 | 1.6 | GO:0001821 | histamine secretion(GO:0001821) |
0.5 | 2.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.5 | 1.6 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.5 | 1.6 | GO:0001845 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.5 | 1.1 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.5 | 1.6 | GO:0010447 | response to acidic pH(GO:0010447) |
0.5 | 9.6 | GO:0045576 | mast cell activation(GO:0045576) |
0.5 | 3.7 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.5 | 1.0 | GO:0046398 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.5 | 1.0 | GO:0015809 | arginine transport(GO:0015809) |
0.5 | 1.0 | GO:2000108 | positive regulation of leukocyte apoptotic process(GO:2000108) |
0.5 | 2.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.5 | 1.5 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.5 | 1.5 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.5 | 1.0 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.5 | 1.0 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.5 | 1.0 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.5 | 1.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.5 | 1.4 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.5 | 3.6 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.4 | 4.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.4 | 0.4 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.4 | 1.3 | GO:0045056 | transcytosis(GO:0045056) |
0.4 | 0.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.4 | 0.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.4 | 1.3 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.4 | 0.9 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.4 | 2.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.4 | 1.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.4 | 2.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.4 | 0.4 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.4 | 1.2 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.4 | 1.2 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.4 | 1.6 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.4 | 3.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 1.6 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.4 | 0.8 | GO:0070266 | necroptotic process(GO:0070266) programmed necrotic cell death(GO:0097300) |
0.4 | 0.8 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.4 | 1.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.4 | 2.3 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.4 | 1.5 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.4 | 0.8 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.4 | 6.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.4 | 1.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 1.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.4 | 1.9 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.4 | 1.5 | GO:0050685 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.4 | 1.5 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.4 | 0.4 | GO:0032621 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
0.4 | 1.8 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.4 | 0.7 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.4 | 1.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.4 | 0.7 | GO:0032613 | interleukin-10 production(GO:0032613) |
0.4 | 1.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.4 | 1.1 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.4 | 0.7 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.4 | 1.8 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.4 | 0.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 0.7 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.3 | 0.7 | GO:1902745 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.3 | 0.3 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.3 | 5.9 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.3 | 1.7 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.3 | 2.8 | GO:0050860 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 1.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.3 | 1.7 | GO:0043368 | positive T cell selection(GO:0043368) |
0.3 | 0.7 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.3 | 1.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.3 | 0.7 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.3 | 1.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.3 | 2.4 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.3 | 0.7 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.3 | 2.0 | GO:0046385 | 2'-deoxyribonucleotide biosynthetic process(GO:0009265) deoxyribose phosphate biosynthetic process(GO:0046385) |
0.3 | 0.7 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.3 | 0.7 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.3 | 3.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 1.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.3 | 1.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.3 | 1.9 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.3 | 1.6 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.3 | 0.3 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.3 | 0.9 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.3 | 0.6 | GO:0002830 | positive regulation of type 2 immune response(GO:0002830) positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.3 | 1.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 5.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.3 | 0.6 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.3 | 1.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 1.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 0.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 0.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 1.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 0.9 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 0.3 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.3 | 0.6 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.3 | 3.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.3 | 0.9 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.3 | 0.6 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.3 | 0.9 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.3 | 1.5 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.3 | 1.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.3 | 0.3 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.3 | 1.2 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.3 | 0.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 1.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 1.2 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.3 | 2.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 0.6 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.3 | 1.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.3 | 0.3 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.3 | 1.1 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.3 | 12.6 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.3 | 1.1 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.3 | 0.6 | GO:0051138 | NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 0.3 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.3 | 1.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 0.3 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.3 | 2.0 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 0.8 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.3 | 1.7 | GO:0042119 | granulocyte activation(GO:0036230) neutrophil activation(GO:0042119) |
0.3 | 0.8 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.3 | 0.8 | GO:1902743 | regulation of lamellipodium assembly(GO:0010591) regulation of lamellipodium organization(GO:1902743) |
0.3 | 0.3 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
0.3 | 1.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 0.5 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.3 | 4.0 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.3 | 2.7 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.3 | 1.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 2.9 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.3 | 1.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.3 | 1.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.3 | 0.8 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 1.9 | GO:0045730 | respiratory burst(GO:0045730) |
0.3 | 0.5 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.3 | 0.8 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 3.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.3 | 0.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.3 | 1.3 | GO:0021707 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.3 | 0.5 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.3 | 0.8 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.3 | 1.0 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.3 | 0.5 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.3 | 1.0 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.3 | 0.5 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.3 | 0.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.3 | 0.8 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 0.3 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.3 | 1.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.3 | 0.5 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.3 | 0.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 0.3 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.3 | 0.3 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.3 | 0.5 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.3 | 10.8 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.2 | 0.7 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 0.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.7 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.2 | 0.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 0.7 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 0.7 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 1.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.7 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.2 | 0.7 | GO:0016559 | peroxisome fission(GO:0016559) |
0.2 | 0.7 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 0.7 | GO:0015825 | L-serine transport(GO:0015825) |
0.2 | 1.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.2 | 1.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.2 | 1.2 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.2 | 0.7 | GO:0042532 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.2 | 0.7 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.2 | 0.9 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.2 | 0.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.7 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 0.7 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.2 | 1.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.5 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.2 | 0.2 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.2 | 2.8 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.9 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 2.1 | GO:0051322 | anaphase(GO:0051322) |
0.2 | 5.5 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.2 | 0.9 | GO:0002507 | tolerance induction(GO:0002507) |
0.2 | 1.8 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.2 | 0.9 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 2.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 3.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.2 | 0.9 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.7 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.2 | 0.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.2 | 0.2 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.2 | 0.9 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.2 | 0.2 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.2 | 0.2 | GO:0035304 | regulation of protein dephosphorylation(GO:0035304) |
0.2 | 0.9 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.2 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.2 | 0.6 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.2 | 0.4 | GO:0006862 | nucleotide transport(GO:0006862) |
0.2 | 0.6 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.4 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 0.4 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.2 | 0.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 6.8 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.2 | 0.4 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.2 | 1.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.6 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.2 | 3.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 0.8 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.2 | 1.5 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.2 | 0.6 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.2 | 0.4 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.2 | 0.8 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 1.8 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.2 | 0.8 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.2 | 0.2 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.2 | 0.4 | GO:0039703 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 0.2 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.2 | 1.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 0.8 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 0.6 | GO:0042026 | protein refolding(GO:0042026) |
0.2 | 0.8 | GO:0002097 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.2 | 0.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 0.2 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 0.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 0.4 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 0.8 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.2 | 0.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 0.8 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.2 | 1.7 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.2 | 0.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.6 | GO:0051168 | nuclear export(GO:0051168) |
0.2 | 0.6 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.2 | 2.1 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.2 | 0.8 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.2 | 2.3 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.2 | 3.1 | GO:0016236 | macroautophagy(GO:0016236) |
0.2 | 1.7 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.2 | 1.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.4 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.2 | 1.5 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.2 | 0.4 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.2 | 0.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 6.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.6 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.2 | 3.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.2 | 0.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.6 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.2 | 0.4 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.2 | 0.7 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.2 | 1.3 | GO:0033363 | secretory granule organization(GO:0033363) |
0.2 | 0.2 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.2 | 0.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.4 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.2 | 3.0 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.2 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 0.6 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.2 | 0.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 0.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.5 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.2 | 0.4 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.2 | 0.4 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.2 | 0.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.2 | 0.7 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 3.0 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.2 | 3.0 | GO:0007032 | endosome organization(GO:0007032) |
0.2 | 13.3 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.2 | 0.5 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 0.4 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.2 | GO:0032329 | serine transport(GO:0032329) |
0.2 | 0.7 | GO:2001234 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.2 | 0.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 0.4 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.2 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 5.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.2 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
0.2 | 0.3 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.9 | GO:0052803 | histidine metabolic process(GO:0006547) imidazole-containing compound metabolic process(GO:0052803) |
0.2 | 1.4 | GO:0095500 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.2 | 1.2 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.2 | 0.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.7 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 0.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.2 | 0.5 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.2 | 0.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.2 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 1.0 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.2 | 0.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.5 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 0.8 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.2 | 7.8 | GO:1902400 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.2 | 0.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 1.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.5 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.2 | 0.3 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.2 | 0.3 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.2 | 1.8 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 0.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.2 | 1.9 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.2 | 5.0 | GO:0034340 | response to type I interferon(GO:0034340) |
0.2 | 1.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 1.8 | GO:0016577 | histone demethylation(GO:0016577) |
0.2 | 0.3 | GO:0060744 | thelarche(GO:0042695) development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) mammary gland branching involved in thelarche(GO:0060744) |
0.2 | 1.8 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.2 | 0.6 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 3.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 0.2 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.2 | 1.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 1.9 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.2 | 1.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.5 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.2 | 0.8 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.2 | 1.1 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.2 | 0.5 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.2 | 1.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.2 | 0.5 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.2 | 0.5 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.2 | 0.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.5 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.2 | 0.5 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.1 | 0.4 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.1 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.4 | GO:0043691 | high-density lipoprotein particle remodeling(GO:0034375) reverse cholesterol transport(GO:0043691) |
0.1 | 0.3 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.6 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.1 | 12.9 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 1.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.1 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.1 | 0.3 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.1 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 1.0 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.9 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.1 | 0.6 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.1 | 0.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.4 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.6 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.1 | 1.3 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 1.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.3 | GO:1903299 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 30.5 | GO:0016568 | chromatin modification(GO:0016568) |
0.1 | 2.0 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.6 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.1 | 0.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.3 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.1 | 1.3 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.1 | 0.4 | GO:0034311 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
0.1 | 0.7 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 2.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 3.2 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.1 | 0.6 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.1 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.1 | 0.4 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 2.7 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.4 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.5 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.8 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.7 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 1.4 | GO:0044766 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.1 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.7 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 1.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 2.0 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.1 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.5 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 2.8 | GO:0036503 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.1 | 1.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 1.1 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.1 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.3 | GO:0010586 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.1 | 3.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.3 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.4 | GO:1901992 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle phase transition(GO:1901989) positive regulation of mitotic cell cycle phase transition(GO:1901992) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.4 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.1 | 0.4 | GO:0048488 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.6 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.1 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.5 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.3 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 1.9 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.5 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.1 | 0.3 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.3 | GO:0000239 | pachytene(GO:0000239) |
0.1 | 0.1 | GO:0051099 | positive regulation of binding(GO:0051099) |
0.1 | 0.9 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 0.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.2 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.7 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 2.2 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.2 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 4.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 9.2 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 1.0 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 0.7 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.9 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.1 | 1.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.5 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.5 | GO:0072676 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.1 | 1.3 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 7.8 | GO:0050658 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) establishment of RNA localization(GO:0051236) |
0.1 | 1.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.1 | GO:0044003 | modification by symbiont of host morphology or physiology(GO:0044003) |
0.1 | 0.2 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 0.2 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.1 | 0.1 | GO:0042663 | endodermal cell fate commitment(GO:0001711) endodermal cell fate specification(GO:0001714) endodermal cell differentiation(GO:0035987) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 0.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.4 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.4 | GO:0090200 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
0.1 | 1.9 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.9 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.8 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.1 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.1 | 0.1 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.1 | 0.2 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.1 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.3 | GO:0033345 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.1 | 0.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.3 | GO:0010954 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.1 | 0.3 | GO:0016137 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.1 | 1.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 1.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.2 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.8 | GO:0009820 | alkaloid metabolic process(GO:0009820) |
0.1 | 0.1 | GO:0050687 | negative regulation of response to biotic stimulus(GO:0002832) negative regulation of defense response to virus(GO:0050687) |
0.1 | 0.3 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 2.9 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 1.2 | GO:0008154 | actin polymerization or depolymerization(GO:0008154) |
0.1 | 0.3 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 12.5 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.1 | 0.6 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.2 | GO:0046471 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.1 | 0.2 | GO:0003094 | regulation of glomerular filtration(GO:0003093) glomerular filtration(GO:0003094) renal filtration(GO:0097205) regulation of renal system process(GO:0098801) |
0.1 | 7.5 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 1.0 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 0.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.1 | 0.4 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.4 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 5.7 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.1 | 1.5 | GO:1990266 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.1 | 0.4 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.1 | 0.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.4 | GO:0045123 | cellular extravasation(GO:0045123) |
0.1 | 0.1 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.2 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.3 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.1 | 0.6 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) |
0.1 | 0.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.8 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.1 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 1.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 1.0 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.1 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.1 | 0.5 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 4.3 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.5 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 1.2 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.1 | GO:0001743 | optic placode formation(GO:0001743) |
0.1 | 0.5 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.1 | 3.3 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.1 | 0.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.7 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.1 | 0.1 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.1 | 0.3 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) bile acid secretion(GO:0032782) |
0.1 | 1.1 | GO:0001906 | cell killing(GO:0001906) |
0.1 | 0.5 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.2 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.8 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.1 | 3.4 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 1.3 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 1.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 1.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.1 | 0.1 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.1 | 0.6 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.2 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.1 | 0.2 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.7 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.3 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.6 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.1 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.1 | 0.7 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.1 | 0.1 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 2.9 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
0.1 | 1.3 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.9 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.4 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.1 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.1 | 0.8 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 2.1 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.1 | 2.9 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.7 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.5 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
0.1 | 0.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.4 | GO:0055062 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.1 | 0.1 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.1 | 0.1 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.1 | 3.5 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.1 | 0.5 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.7 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 0.5 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.1 | 0.3 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.1 | 0.3 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.1 | 0.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.5 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.1 | 0.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.6 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.7 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.1 | 1.8 | GO:0006914 | autophagy(GO:0006914) |
0.1 | 0.1 | GO:1900120 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.1 | 0.1 | GO:0003157 | endocardium development(GO:0003157) endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.1 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.1 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.1 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 2.5 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.5 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.2 | GO:0048679 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.1 | 24.7 | GO:0006955 | immune response(GO:0006955) |
0.1 | 0.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.9 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 1.3 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.1 | 0.2 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.2 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.1 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.1 | 0.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.1 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.1 | 0.5 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 2.3 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.1 | 0.2 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.3 | GO:0052646 | glycerol-3-phosphate metabolic process(GO:0006072) alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.4 | GO:0042116 | macrophage activation(GO:0042116) |
0.1 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 2.8 | GO:0043039 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.1 | 0.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.3 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.9 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.4 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.1 | 1.1 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 0.1 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.1 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.4 | GO:0042462 | photoreceptor cell development(GO:0042461) eye photoreceptor cell development(GO:0042462) |
0.1 | 0.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.4 | GO:0002440 | production of molecular mediator of immune response(GO:0002440) |
0.1 | 0.2 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.1 | 0.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.1 | GO:0046530 | photoreceptor cell differentiation(GO:0046530) |
0.1 | 0.1 | GO:0046479 | glycosylceramide catabolic process(GO:0046477) glycosphingolipid catabolic process(GO:0046479) |
0.1 | 0.1 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 0.3 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.8 | GO:0002697 | regulation of immune effector process(GO:0002697) |
0.1 | 0.4 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.6 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.4 | GO:0019674 | NAD metabolic process(GO:0019674) |
0.1 | 0.3 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.2 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.1 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.1 | 0.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.5 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.1 | 0.5 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.1 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.1 | GO:0019614 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) dopamine catabolic process(GO:0042420) catecholamine catabolic process(GO:0042424) |
0.1 | 0.3 | GO:1903078 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 6.0 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 1.2 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 0.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.4 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.1 | 0.4 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.3 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 0.2 | GO:0072665 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.1 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 0.2 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.1 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 3.1 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 2.7 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.4 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.9 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.5 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.1 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.5 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.1 | 8.7 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 0.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.9 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.1 | 0.6 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 2.6 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.1 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.1 | 0.2 | GO:0045329 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.1 | 0.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.8 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.1 | 1.4 | GO:0044843 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.1 | 0.1 | GO:0050795 | regulation of behavior(GO:0050795) |
0.1 | 0.3 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.1 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.1 | 0.8 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.1 | 5.8 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.3 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.1 | 2.4 | GO:0070085 | glycosylation(GO:0070085) |
0.1 | 0.1 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.1 | 0.3 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.1 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.1 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.1 | 0.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.3 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.0 | 3.0 | GO:0031497 | chromatin assembly(GO:0031497) |
0.0 | 0.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.0 | 0.2 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 9.2 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.2 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.0 | 0.2 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.3 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.0 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 5.2 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 1.1 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.0 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.0 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) negative regulation of action potential(GO:0045759) |
0.0 | 0.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.5 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.5 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.0 | GO:0060298 | regulation of sarcomere organization(GO:0060297) positive regulation of sarcomere organization(GO:0060298) |
0.0 | 0.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.0 | 0.3 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.0 | 0.1 | GO:0006473 | protein acetylation(GO:0006473) |
0.0 | 0.2 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.0 | GO:0034620 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) |
0.0 | 0.5 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.1 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.0 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.0 | 0.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.2 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.3 | GO:0018105 | peptidyl-serine phosphorylation(GO:0018105) |
0.0 | 1.1 | GO:0006638 | neutral lipid metabolic process(GO:0006638) acylglycerol metabolic process(GO:0006639) |
0.0 | 0.1 | GO:0009394 | 2'-deoxyribonucleotide metabolic process(GO:0009394) deoxyribose phosphate metabolic process(GO:0019692) |
0.0 | 0.0 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.2 | GO:0000718 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.0 | 0.0 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0032364 | oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
0.0 | 0.1 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 1.0 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.0 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0043049 | otic placode formation(GO:0043049) |
0.0 | 0.0 | GO:0097061 | dendritic spine development(GO:0060996) dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine development(GO:0060998) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.1 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.0 | 0.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.0 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.0 | GO:0060456 | regulation of saliva secretion(GO:0046877) positive regulation of digestive system process(GO:0060456) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.1 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.1 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.1 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.0 | GO:0016045 | detection of bacterium(GO:0016045) |
0.0 | 0.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0045143 | homologous chromosome segregation(GO:0045143) |
0.0 | 0.0 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.0 | 0.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.0 | 0.1 | GO:0010039 | response to iron ion(GO:0010039) |
0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.1 | GO:0015853 | purine nucleobase transport(GO:0006863) adenine transport(GO:0015853) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 0.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.2 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.3 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.1 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.0 | 0.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.1 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.0 | 0.1 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.0 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
0.0 | 0.1 | GO:0000087 | mitotic M phase(GO:0000087) |
0.0 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.0 | GO:0030832 | regulation of actin filament length(GO:0030832) |
0.0 | 0.1 | GO:0051904 | pigment granule transport(GO:0051904) |
0.0 | 0.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.1 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.0 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.2 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0009451 | RNA modification(GO:0009451) |
0.0 | 0.0 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.0 | GO:0045007 | depurination(GO:0045007) |
0.0 | 0.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.1 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.0 | 0.3 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.0 | 0.0 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.0 | 0.1 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) purine nucleoside triphosphate biosynthetic process(GO:0009145) |
0.0 | 0.0 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.5 | GO:0006310 | DNA recombination(GO:0006310) |
0.0 | 0.1 | GO:0051053 | negative regulation of DNA metabolic process(GO:0051053) |
0.0 | 1.6 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.0 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.0 | 2.4 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.0 | 1.2 | GO:0006281 | DNA repair(GO:0006281) |
0.0 | 0.0 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.1 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.1 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.0 | 0.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.0 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.0 | GO:0043500 | muscle adaptation(GO:0043500) |
0.0 | 0.9 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.0 | 0.0 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.0 | 0.0 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.0 | 0.1 | GO:0042438 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.0 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.0 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
0.0 | 0.1 | GO:0046148 | pigment biosynthetic process(GO:0046148) |
0.0 | 0.0 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.0 | 0.1 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.0 | 0.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.0 | GO:0032663 | regulation of interleukin-2 production(GO:0032663) |
0.0 | 0.0 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.0 | 0.0 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.1 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.1 | GO:0007286 | spermatid development(GO:0007286) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 5.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.8 | 10.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.7 | 2.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.7 | 4.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.7 | 2.7 | GO:0070820 | tertiary granule(GO:0070820) |
0.6 | 1.9 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.6 | 5.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.5 | 1.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.5 | 1.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 4.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.4 | 1.3 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 0.4 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 1.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.4 | 1.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.4 | 1.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 2.6 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.4 | 0.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 1.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 0.7 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.3 | 1.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 1.6 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 4.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 3.4 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 2.2 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.3 | 0.9 | GO:0005827 | polar microtubule(GO:0005827) |
0.3 | 2.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 0.9 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.3 | 0.9 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.3 | 3.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 0.9 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 0.6 | GO:0038201 | TOR complex(GO:0038201) |
0.3 | 1.9 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.3 | 1.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 0.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 3.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 2.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.3 | 0.3 | GO:0001939 | female pronucleus(GO:0001939) |
0.3 | 0.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 2.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 1.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 1.5 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 4.0 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.2 | 1.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.2 | GO:0001740 | Barr body(GO:0001740) |
0.2 | 3.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 1.4 | GO:0005884 | actin filament(GO:0005884) |
0.2 | 1.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 0.7 | GO:0031904 | endosome lumen(GO:0031904) |
0.2 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.2 | 0.9 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 1.1 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.2 | 0.9 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.2 | 1.3 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 0.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 2.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 1.9 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.2 | 0.8 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.2 | 1.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 1.2 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 1.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 1.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 2.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 6.0 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 1.0 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) |
0.2 | 1.7 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 3.1 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 1.3 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.2 | 1.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 10.7 | GO:0016605 | PML body(GO:0016605) |
0.2 | 1.7 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.2 | 0.7 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.2 | 0.2 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 0.7 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 0.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 0.5 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.2 | 0.7 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 0.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 0.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 7.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 18.5 | GO:0016607 | nuclear speck(GO:0016607) |
0.2 | 0.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 0.5 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 1.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 1.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.3 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 1.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 0.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 0.5 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.2 | 5.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 2.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 1.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.6 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 8.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 1.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 2.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.3 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 2.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 1.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 1.0 | GO:0070822 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.1 | 0.7 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 2.5 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 1.2 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 1.0 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 1.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 1.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 1.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.8 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.1 | 0.4 | GO:0098573 | integral component of mitochondrial membrane(GO:0032592) intrinsic component of mitochondrial membrane(GO:0098573) |
0.1 | 15.1 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.7 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.8 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 1.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 10.5 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.5 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 0.8 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 1.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.4 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.7 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.9 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.4 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.5 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 1.5 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 1.0 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 5.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 10.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 1.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.1 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.1 | 0.5 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.7 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 4.7 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 2.1 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 4.2 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 0.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.8 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.3 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 2.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.2 | GO:0001741 | XY body(GO:0001741) |
0.1 | 4.5 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.1 | 0.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 1.4 | GO:0031248 | histone acetyltransferase complex(GO:0000123) protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.1 | 0.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.7 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.1 | 0.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.7 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.1 | 0.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.1 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.5 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 1.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 2.5 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.5 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 1.3 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 5.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.8 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 6.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 1.1 | GO:0030663 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
0.1 | 0.4 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.7 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.1 | 0.7 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 17.6 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.1 | 2.9 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.1 | 10.5 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.6 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 2.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.2 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 1.2 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.9 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 1.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.8 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.1 | 0.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 1.1 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 5.4 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.6 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.3 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 1.0 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.3 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 1.3 | GO:0070469 | respiratory chain(GO:0070469) |
0.1 | 0.4 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 0.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 1.5 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.2 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 5.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 41.3 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.4 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 4.6 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 2.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 94.7 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 5.6 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.7 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 4.8 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 1.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 0.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 1.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 32.4 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.9 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.1 | 4.2 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 1.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 2.1 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.1 | 0.8 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.9 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.2 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 21.8 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.7 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 6.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.0 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 22.0 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.9 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.1 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.0 | 0.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.4 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.0 | GO:0036379 | myofilament(GO:0036379) |
0.0 | 0.2 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.5 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.2 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.3 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.2 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 44.2 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.0 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.2 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 2.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.0 | GO:1990234 | transferase complex(GO:1990234) |
0.0 | 0.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.3 | GO:0016459 | myosin complex(GO:0016459) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.2 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
1.1 | 3.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.0 | 2.9 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.9 | 2.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.7 | 2.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.7 | 2.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.6 | 1.9 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.6 | 1.9 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.6 | 0.6 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.6 | 1.9 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.6 | 3.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.6 | 1.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.6 | 1.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.6 | 2.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.6 | 9.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 4.5 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 0.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) translation regulator activity, nucleic acid binding(GO:0090079) |
0.5 | 1.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.5 | 1.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.4 | 1.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 2.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.4 | 1.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.4 | 1.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 3.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.4 | 1.6 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.4 | 3.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.4 | 1.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.4 | 1.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.4 | 2.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 1.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.4 | 1.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.4 | 1.1 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.4 | 0.7 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.4 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 1.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 17.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 2.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.4 | 3.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 5.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 13.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 1.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 1.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 2.3 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.3 | 1.6 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.3 | 1.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 2.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 0.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 3.1 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.3 | 0.9 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 1.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 0.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 0.9 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.3 | 2.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 0.9 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.3 | 0.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 1.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 1.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 2.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.3 | 2.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 0.8 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.3 | 3.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 0.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 1.1 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.3 | 3.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.3 | 7.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.3 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 0.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 0.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.3 | 0.5 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.3 | 0.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 0.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 1.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 1.8 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.3 | 1.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 0.8 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.3 | 0.8 | GO:0004875 | complement receptor activity(GO:0004875) |
0.3 | 1.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.3 | 0.8 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.3 | 2.3 | GO:0019864 | IgG binding(GO:0019864) |
0.3 | 2.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 1.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 1.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 1.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.3 | 0.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 1.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.3 | 1.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 0.8 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 0.5 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.2 | 1.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 2.5 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.2 | 0.7 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 1.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 1.5 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.7 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.2 | 5.6 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 1.2 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.2 | 7.5 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 0.7 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 0.7 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 2.1 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.2 | 1.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 1.0 | GO:0045569 | TRAIL binding(GO:0045569) |
0.2 | 1.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 2.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.2 | 3.8 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.2 | 0.7 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.2 | 0.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 0.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 0.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 3.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 0.7 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.2 | 0.9 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 3.9 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 0.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 3.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 1.1 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.2 | 0.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 1.3 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 0.7 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 0.7 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.2 | 1.3 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.2 | 0.9 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 1.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 0.7 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 1.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 0.9 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 1.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.6 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 1.1 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.2 | 1.9 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.2 | 1.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.8 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 1.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 2.7 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.2 | 2.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 0.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 3.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 1.0 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.8 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 0.8 | GO:0004340 | glucokinase activity(GO:0004340) |
0.2 | 0.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 1.0 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 0.4 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.2 | 1.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 3.0 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 0.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 0.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 0.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 4.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 0.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 0.8 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 1.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.6 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 1.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 0.8 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 5.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.2 | 0.6 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 0.9 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 0.6 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.2 | 0.7 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 0.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 1.1 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 1.8 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.2 | 0.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 1.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 1.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.2 | 1.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 3.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.2 | 1.4 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 1.6 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.2 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 4.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 2.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.9 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.2 | 0.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 0.7 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 1.6 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.2 | 0.5 | GO:0004802 | transketolase activity(GO:0004802) |
0.2 | 0.5 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.2 | 0.7 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.2 | 0.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 1.7 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 1.0 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.5 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 1.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 1.8 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 2.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.8 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.2 | 0.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.2 | 0.5 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.2 | 0.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 1.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 0.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.2 | 0.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 9.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 0.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 3.0 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.2 | 0.6 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.2 | 0.6 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.2 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 3.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 1.1 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.2 | 3.9 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 2.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.2 | 0.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 0.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 0.5 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.2 | 1.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 2.6 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 3.9 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.2 | 1.5 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 1.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.4 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 1.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 3.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 1.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 1.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.7 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 1.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.6 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 1.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 1.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.4 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.1 | 3.2 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 0.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.5 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 1.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.4 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.1 | 4.2 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 6.3 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 2.1 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 0.5 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 0.8 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 1.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 1.5 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.9 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.4 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.6 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 0.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 1.0 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.1 | 1.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.4 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 1.6 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 4.3 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.8 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 4.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.1 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 3.3 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.3 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 0.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 5.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.3 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.2 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 4.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.5 | GO:0016531 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
0.1 | 1.1 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.5 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 4.5 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 10.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.6 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.1 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.1 | 0.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 8.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.3 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 2.7 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.1 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.1 | 0.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.1 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.2 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 2.0 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 0.9 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 0.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.2 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.2 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 2.2 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 2.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 1.5 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 1.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 1.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 9.2 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.2 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.1 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.4 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.8 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.5 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.8 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 2.2 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.1 | 0.4 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.4 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 0.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.5 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.1 | 0.2 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 0.7 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.1 | 0.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.1 | 0.3 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 1.8 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.4 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.1 | 1.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.6 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.7 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 17.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 3.1 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 1.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 1.0 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.1 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.1 | 1.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.2 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 1.9 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 4.9 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 23.5 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.4 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.9 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.2 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 1.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 5.7 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.1 | 0.1 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.1 | 0.1 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.7 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.1 | 0.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 1.4 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.7 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 6.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.4 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 1.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.3 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 1.1 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 0.1 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 1.7 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.2 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.3 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 1.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.4 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.1 | 0.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.2 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.1 | 25.7 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.2 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 0.1 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 4.3 | GO:0016874 | ligase activity(GO:0016874) |
0.1 | 4.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 1.2 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.1 | 1.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.1 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 1.2 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 2.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.1 | 0.9 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.3 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.3 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.2 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.7 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 0.2 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) glucosyltransferase activity(GO:0046527) |
0.1 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.4 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.3 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 4.5 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.0 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 2.6 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.7 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 5.6 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.0 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.4 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 2.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.2 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.8 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 1.9 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.0 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.7 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
0.0 | 0.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.0 | 0.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.3 | GO:0019001 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.0 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 4.9 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.4 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.0 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.0 | 0.2 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 0.3 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.0 | 0.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.3 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.0 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.0 | 0.2 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 1.7 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 0.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 0.0 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.7 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.1 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.4 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.0 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.0 | 7.1 | GO:0035639 | ATP binding(GO:0005524) purine ribonucleoside triphosphate binding(GO:0035639) |
0.0 | 0.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.4 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.0 | 0.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 17.2 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.1 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.0 | 0.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.0 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 10.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.8 | 6.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.6 | 17.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.6 | 33.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.6 | 0.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.6 | 6.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.6 | 4.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.6 | 16.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.5 | 1.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.5 | 3.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 6.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.4 | 6.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 10.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.4 | 1.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 3.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 7.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 0.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 6.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 1.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 3.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 0.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.3 | 6.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 7.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 4.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 5.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 2.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 1.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 0.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 0.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 0.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 7.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 2.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 3.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 0.8 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 3.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 1.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 3.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 1.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 1.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 2.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 2.8 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 1.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 3.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 4.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 2.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 7.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 4.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 1.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 3.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 3.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 3.1 | PID ATM PATHWAY | ATM pathway |
0.1 | 3.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 0.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 2.4 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.9 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 2.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 2.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 2.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 3.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 1.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 2.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 1.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 1.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 1.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 1.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.6 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.7 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.2 | PID RHOA PATHWAY | RhoA signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.9 | 22.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.7 | 8.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.6 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.5 | 5.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 5.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 7.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.5 | 8.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.5 | 1.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 4.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 0.9 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.5 | 8.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.4 | 0.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.4 | 1.3 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.4 | 6.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 3.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 6.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 1.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.3 | 3.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 14.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 1.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 1.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 3.6 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.3 | 2.9 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.3 | 1.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.3 | 4.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.3 | 7.6 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 8.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 8.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 3.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 1.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 12.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 4.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 1.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.3 | 3.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 3.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 2.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 3.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 0.5 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.2 | 0.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 4.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 0.9 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.2 | 0.9 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 4.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 2.4 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 1.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 3.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 5.4 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.2 | 0.6 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.2 | 3.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 6.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 3.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 1.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 2.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 0.4 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 2.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 1.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 1.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 0.2 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 0.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 7.9 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 1.0 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 2.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 1.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 1.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 1.0 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 1.6 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.2 | 2.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 3.9 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 0.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 1.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 0.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 1.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 15.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 2.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 1.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.6 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.1 | 0.3 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 2.4 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 1.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 2.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 1.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 0.3 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 2.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.9 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 2.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.8 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.5 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 1.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 1.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 2.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 3.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 3.1 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 1.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.4 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.1 | 1.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 7.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 6.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 2.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 8.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 10.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.3 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 0.2 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
0.1 | 1.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 2.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 1.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.9 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 3.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 4.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 2.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 2.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.6 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 1.4 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 0.8 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 1.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 3.4 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 1.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.8 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 5.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 4.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 4.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 5.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 0.1 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 4.0 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 3.4 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 1.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.8 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.1 | 0.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.1 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 0.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 3.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 8.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 1.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 1.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 5.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 1.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.4 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 0.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 1.7 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 0.2 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.1 | 0.3 | REACTOME APOPTOSIS | Genes involved in Apoptosis |
0.1 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.9 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.1 | 1.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 2.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.5 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.5 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.0 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 1.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.2 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.0 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 1.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.8 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.0 | 0.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.2 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.0 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 1.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 1.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.3 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.0 | 0.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.5 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |